A business in context
KYMR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-04 | Adams Brian | S · Sale | Common Stock | 1209.0 | 115.55 |
| 2026-09-04 | Adams Brian | S · Sale | Common Stock | 3025.0 | 116.81 |
| 2026-09-04 | Adams Brian | S · Sale | Common Stock | 2137.0 | 117.57 |
| 2026-07-27 | Rooney Terence | A · Grant / award | Common Stock | 38000.0 | 0.0 |
| 2026-07-27 | Rooney Terence | A · Grant / award | Stock Option (Right to Buy) | 76000.0 | 0.0 |
| 2026-07-07 | Mainolfi Nello | M · Exercise / conversion | Common Stock | 50000.0 | 2.08 |
| 2026-07-07 | Mainolfi Nello | S · Sale | Common Stock | 50000.0 | 119.0 |
| 2026-07-07 | Mainolfi Nello | M · Exercise / conversion | Stock Option (Right to Buy) | 4441.0 | 0.0 |
| 2026-07-07 | Mainolfi Nello | M · Exercise / conversion | Stock Option (Right to Buy) | 45559.0 | 0.0 |
| 2026-07-01 | Goodman Noah | S · Sale | Common Stock | 3389.0 | 114.29 |
| 2026-07-01 | Mainolfi Nello | M · Exercise / conversion | Common Stock | 80000.0 | 2.08 |
| 2026-07-01 | Mainolfi Nello | S · Sale | Common Stock | 1883.0 | 112.8 |
| 2026-07-01 | Mainolfi Nello | S · Sale | Common Stock | 6626.0 | 113.98 |
| 2026-07-01 | Mainolfi Nello | S · Sale | Common Stock | 44050.0 | 115.69 |
| 2026-07-01 | Mainolfi Nello | S · Sale | Common Stock | 24105.0 | 114.96 |
| 2026-07-01 | Mainolfi Nello | S · Sale | Common Stock | 3336.0 | 116.56 |
| 2026-07-01 | Mainolfi Nello | M · Exercise / conversion | Stock Option (Right to Buy) | 80000.0 | 0.0 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 1100.0 | 112.79 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 4110.0 | 114.19 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 51375.0 | 114.77 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 1700.0 | 111.57 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 1500.0 | 110.54 |
| 2026-06-30 | Jacobs Bruce N. | M · Exercise / conversion | Common Stock | 61378.0 | 5.33 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 7971.0 | 115.82 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 3200.0 | 117.7 |
| 2026-06-30 | Jacobs Bruce N. | S · Sale | Common Stock | 6153.0 | 116.99 |
| 2026-06-30 | Jacobs Bruce N. | M · Exercise / conversion | Stock Option (Right to Buy) | 61378.0 | 0.0 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 10848.0 | 108.28 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 7968.0 | 109.75 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 7723.0 | 110.67 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 770.0 | 105.78 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 2133.0 | 106.63 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 2698.0 | 107.76 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1498.0 | 108.28 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1104.0 | 109.75 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1078.0 | 110.67 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 130.0 | 111.2 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 19419.0 | 107.76 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 14798.0 | 106.63 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 5549.0 | 105.78 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 934.0 | 111.2 |
Identity & relationships
SEC issuer · 0001815442Kymera Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Kymera Therapeutics · alias · wikidata
- Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-10-01
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.07M | $50.56M |
| 2023-12-31 | $78.59M | $86.90M |
| 2022-12-31 | $46.83M | $53.90M |
| 2021-12-31 | $72.83M | $90.55M |
| 2020-12-31 | $34.03M | $44.31M |
| 2019-12-31 | $2.93M | $3.87M |